Physician profile
Robert Massaro
NPI 1679500482
$11,464.65
in general payments reported to CMS, 2019-2025
19 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.49 · 2020: $14.19 · 2021: $300 · 2022: $387 · 2023: $148 · 2024: $10K · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $10K · Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $10,152.00 |
| Food and Beverage | $546.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $10,305.21 | 2023-2025 | Jada System |
| Momentis Surgical INC. | $183.00 | 2022 | |
| Hologic Sales and Service, LLC | $178.52 | 2020-2022 | |
| Alydia Health | $143.29 | 2021 | |
| Davol INC. | $133.77 | 2019-2023 | Arista Ah Flexitip |
| Coopersurgical, INC. | $112.09 | 2022-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator, Onetrac Lx |
| Heron Therapeutics, INC. | $78.87 | 2021-2025 | Zynrelef |
| Abbvie INC. | $73.87 | 2019-2024 | |
| Innovation Technologies INC | $63.59 | 2022-2024 | Irrisept |
| Convatec INC. | $28.57 | 2025 | |
| Roche Diagnostics Corporation | $25.32 | 2021 | |
| Exeltis, USA INC. | $19.09 | 2024 | Slynd |
| Daiichi Sankyo INC. | $19.01 | 2025 | Injectafer |
| Sage Therapeutics, LLC | $18.02 | 2024 | |
| Mayne Pharma Commercial LLC | $17.89 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $17.00 | 2025 | Phexxi, Solosec, Phexx |
| Vertex Pharmaceuticals Incorporated | $16.46 | 2025 | |
| Minerva Surgical, INC | $15.62 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Massaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.